Epizyme Inc. buy melinda
Start price
14.06.17
/
50%
€11.84
Target price
22.06.17
€16.24
Performance (%)
10.06%
End price
22.06.17
€13.03
Summary
This prediction ended on 22.06.17 with a price of €13.03. The prediction had a final performance of 10.06%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epizyme Inc. | - | - | - | - |
| iShares Core DAX® | -0.681% | -4.853% | 1.940% | 54.334% |
| iShares Nasdaq 100 | -0.033% | 2.862% | 18.901% | 82.618% |
| iShares Nikkei 225® | -0.536% | -5.024% | 28.152% | 55.637% |
| iShares S&P 500 | -0.211% | 0.925% | 13.685% | 61.213% |
Comments by melinda for this prediction
In the thread Epizyme Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
(Vom Mitglied beendet)